Significant progress on breakthrough cancer therapy
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
Showing 1 - 12 of 12 results
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
ANSTO works in partnerships and collaborative ventures with national and international organisations. Partner with ANSTO.
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
ANSTO expert in molecular imaging contributed to international workshop.
Participants undertook IAEA training hosted by Macquarie University and ANSTO on use of radionuclides for soil and water investigations.
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.
Theinstrument is typically used to study diffusing water molecules or yet larger molecules like polymers or biological molecules. In addition, Emu can reveal quantum-mechanical tunnelling.
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
ANSTO facilitating coordinated effort to find the nexus that leads to chronic kidney disease of unknown origin